GA
GoalVest Advisory’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1
| Closed | -$634 | – | 498 |
|
|
2025
Q1 | $634 | Buy |
+1
| New | +$634 | ﹤0.01% | 353 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 463 |
|
|
2023
Q4 | – | Sell |
-14
| Closed | -$11.5K | – | 466 |
|
|
2023
Q3 | $11.5K | Hold |
14
| – | – | 0.01% | 263 |
|
|
2023
Q2 | $10.1K | Hold |
14
| – | – | 0.01% | 252 |
|
|
2023
Q1 | $11.5K | Hold |
14
| – | – | 0.01% | 181 |
|
|
2022
Q4 | $10.1K | Hold |
14
| – | – | 0.01% | 182 |
|
|
2022
Q3 | $10K | Hold |
14
| – | – | 0.01% | 190 |
|
|
2022
Q2 | $8K | Sell |
14
-204
| -94% | -$117K | 0.01% | 260 |
|
|
2022
Q1 | $152K | Buy |
+218
| New | +$152K | 0.09% | 117 |
|
|
2021
Q2 | $338K | Sell |
606
-284
| -32% | -$158K | 0.21% | 104 |
|
|
2021
Q1 | $421K | Buy |
890
+11
| +1% | +$5.2K | 0.31% | 94 |
|
|
2020
Q4 | $425K | Buy |
+879
| New | +$425K | 0.36% | 78 |
|